CAS: 509077-99-0 - Ertumaxomab
Formule :Unspecified
- Synonymes :
- Immunoglobulin G2a, anti-(human HER-2/neu) (mouse monoclonal 2502A/TP-A-02/TPBs03 heavy chain), disulfide with mouse monoclonal 2502A/TP-A-02/TPBs03 light chain, disulfide with immunoglobulin G2b, anti-(human CD3 (antigen)) (rat monoclonal 26/II/6-1.2/TPBs03 heavy chain), disulfide with rat monoclonal 26/II/6-1.2/TPBs03 light chain
- Immunoglobulin G2a, anti-(human neu (receptor)) (mouse monoclonal 2502A/TP-A-02/TPBs03 heavy chain), disulfide with mouse monoclonal 2502A/TP-A-02/TPBs03 light chain, disulfide with immunoglobulin G2b, anti-(human CD3 (antigen)) (rat monoclonal 26/II/6-1.2/TPBs03 heavy chain), disulfide with rat monoclonal 26/II/6-1.2/TPBs03 light chain
- Immunoglobulin G2a, anti-(human c-erbB2 (receptor)) (mouse monoclonal 2502A/TP-A-02/TPBs03 heavy chain), disulfide with mouse monoclonal 2502A/TP-A-02/TPBs03 light chain, disulfide with immunoglobulin G2b, anti-(human CD3 (antigen)) (rat monoclonal 26/II/6-1.2/TPBs03 heavy chain), disulfide with rat monoclonal 26/II/6-1.2/TPBs03 light chain
- Ertumaxomab
| Marque | Informations sur le produit | Degré de pureté | Gamme de prix | Livraison estimée |
|---|---|---|---|---|
 | Ertumaxomab REF : 3D-CLA1169CAS : 509077-99-0 | - - - | À demander | lun 04 Nov 24 |
Ertumaxomab
CAS :509077-99-0
Anti-human CD22 recombinant antibody bispecific antibody targeting HER2/neu and CD3.
Ref: 3D-CLA1169
| Taille indéfinie | À demander |
Livraison estimée en/au États-Unis, le lundi 4 novembre 2024
